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Modulation of Endothelial Cell KCa3.1 Channels During
Endothelium-Derived Hyperpolarizing Factor Signaling in
Mesenteric Resistance Arteries
Kim A. Dora, Nicola T. Gallagher, Alister McNeish, Christopher J. Garland
Abstract—Arterial hyperpolarization to acetylcholine (ACh) reflects coactivation of KCa3.1 (IKCa) channels and KCa2.3
(SKCa) channels in the endothelium that transfers through myoendothelial gap junctions and diffusible factor(s) to affect
smooth muscle relaxation (endothelium-derived hyperpolarizing factor [EDHF] response). However, ACh can
differentially activate KCa3.1 and KCa2.3 channels, and we investigated the mechanisms responsible in rat mesenteric
arteries. KCa3.1 channel input to EDHF hyperpolarization was enhanced by reducing external [Ca2]o but blocked either
with forskolin to activate protein kinase A or by limiting smooth muscle [Ca2]i increases stimulated by phenylephrine
depolarization. Imaging [Ca2]i within the endothelial cell projections forming myoendothelial gap junctions revealed
increases in cytoplasmic [Ca2]i during endothelial stimulation with ACh that were unaffected by simultaneous increases
in muscle [Ca2]i evoked by phenylephrine. If gap junctions were uncoupled, KCa3.1 channels became the predominant
input to EDHF hyperpolarization, and relaxation was inhibited with ouabain, implicating a crucial link through
Na/K-ATPase. There was no evidence for an equivalent link through KCa2.3 channels nor between these channels and
the putative EDHF pathway involving natriuretic peptide receptor-C. Reconstruction of confocal z-stack images from
pressurized arteries revealed KCa2.3 immunostain at endothelial cell borders, including endothelial cell projections,
whereas KCa3.1 channels and Na/K-ATPase 2/3 subunits were highly concentrated in endothelial cell projections
and adjacent to myoendothelial gap junctions. Thus, extracellular [Ca2]o appears to modify KCa3.1 channel activity
through a protein kinase A–dependent mechanism independent of changes in endothelial [Ca2]i. The resulting
hyperpolarization links to arterial relaxation largely through Na/K-ATPase, possibly reflecting K acting as an EDHF.
In contrast, KCa2.3 hyperpolarization appears mainly to affect relaxation through myoendothelial gap junctions. Overall,
these data suggest that K and myoendothelial coupling evoke EDHF-mediated relaxation through distinct,
definable pathways. (Circ Res. 2008;102:1247-1255.)
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The importance of the arterial endothelium for relaxationof the subjacent smooth muscle is well established.
Whatever the final endothelium-derived effector, a key event
is an initial increase in endothelial cell [Ca2]i. In the case of
endothelium-derived hyperpolarizing factor (EDHF) (the
NO- and prostanoid-independent pathway), this increase
crucially activates endothelial KCa2.3 and KCa3.1 channels.
Activation of these KCa channels leads on to arterial hyper-
polarization and dilation (see elsewhere for review1), and a
changing role for each subtype has been implicated in
pathological responses within blood vessels.2,3
Although activation of both KCa2.3 and KCa3.1 channels
leads ultimately to vascular dilation, each can provide a
variable contribution to EDHF hyperpolarization. Individual
input is influenced by the extent of ongoing arterial (back-
ground) constriction. Increasing endothelial cell [Ca2]i (with
acetylcholine [ACh]) in quiescent rat mesenteric arteries
hyperpolarizes the resting membrane potential through KCa2.3
channels alone, but, during smooth muscle depolarization and
the associated contraction necessary to observe EDHF relax-
ation, KCa3.1 channels are also activated.4 This differential
activation correlates with a distinct subcellular distribution of
the channels. KCa3.1 channels are localized within the endo-
thelial cell projections through the internal elastic lamina
(IEL) that form myoendothelial gap junction (MEGJs) with
the adjacent smooth muscle. In contrast, KCa2.3 channels are
diffusely distributed throughout the plasmalemma of endo-
thelial cells.5 How the different channel types are activated
independently is not known, but concentrating KCa3.1 chan-
nels within the narrow endothelial cell projections may hinder
access of activating Ca2 from the main body of the endo-
thelial cells, while, perhaps, facilitating activation by a signal
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derived from or associated with the contracting smooth
muscle. In small arteries and arterioles, Ca2 and/or a Ca2
signal has been shown to spread from the muscle to the
endothelium.6–8 In the mesenteric artery, this process relies
on Ca2 signaling via MEGJs.7,8 Extracellular Ca2 levels
([Ca2]o) may also have a significant influence on endothelial
cell signaling. In the mesenteric artery, an extracellular
calcium-sensing receptor (CaSR) on the endothelium links to
activate KCa3.1 channels selectively and appears to colocalize
with this channel (but not with KCa2.3 channels).9 This raises
the possibility that alterations in extracellular Ca2 concen-
tration may help determine the relative contribution from
KCa3.1/2.3 channels. In addition, KCa3.1 but not KCa2.3
channel activity is inhibited by protein kinase A phosphory-
lation in enteric neurons, indicating regulation may occur
independently of intracellular [Ca2] change.10–12
In the rat mesenteric artery, transfer of endothelial hyper-
polarization to the muscle, in part, reflects K ion efflux
through endothelial KCa channels and, in part, spread of
hyperpolarization via MEGJs.13–16 Extracellular K, mimick-
ing its action as a diffusible EDHF, stimulates smooth muscle
hyperpolarization and relaxation primarily by activating Na/
K-ATPase.17 However, in situ, the ability of K to act as an
EDHF is inversely related to ongoing arterial contraction
because, as contraction increases, Na/K-ATPase activity is
swamped by K leaving the smooth muscle through BKCa
channels.17–19 In contrast, MEGJs operating in parallel to K
enable a constant spread of hyperpolarization, and this route
to relaxation thus becomes predominant as arterial tone
approaches maximum.16 Therefore, 1 possibility is that
KCa2.3 and KCa3.1 channels may each separately underlie 1 of
these routes to vasodilation. In support of this possibility,
recent evidence from rat mesenteric artery has suggested that
KCa2.3 channel activation may be intimately linked to the
release of C-type natriuretic peptide, which acts as a diffus-
ible EDHF through natriuretic peptide receptor-C.20
The aims of the present study were, therefore: (1) to
investigate how KCa3.1 channels are independently activated;
and (2) to show whether the subcellular distribution of
KCa2.3/KCa3.1 channels within rat mesenteric endothelial cells
can be correlated with discrete EDHF pathways, with func-
tional consequences for relaxation and of direct relevance to
endothelial changes associated with vascular disease.
Materials and Methods
An expanded Materials and Methods section in the online data
supplement, available at http://circres.ahajournals.org, gives full
details regarding the experimental techniques used. These included
intracellular sharp microelectrode recording and simultaneous ten-
sion measurements, Ca2 imaging from both smooth muscle and
endothelial cells, and immunohistochemistry of rat isolated small
mesenteric arteries.
Results
Reducing External [Ca2]o Recruits KCa3.1
Channel Input to EDHF Hyperpolarization
Reducing external [Ca2]o from 2.5 to 1.0 mmol/L slightly
reduced smooth muscle resting membrane potential (from
51.71.6 to 47.80.9 mV, n7 and 12) and depressed
the cumulative EDHF hyperpolarization to ACh (maximal
increase 23.92.4 mV [n7] and 20.11.7 mV [n12],
respectively; Figure 1A). In contrast to the situation in
2.5 mmol/L Ca2 (and see also Crane et al4), apamin failed to
block EDHF hyperpolarization in 1 mmol/L Ca2 (n4).
Furthermore, low [Ca2]o facilitated the ability of the KCa3.1
channel activator 1-EBIO (100 and 300 mol/L) to evoke
smooth muscle hyperpolarization (Figure 1B). In separate
experiments using 1.0 mmol/L [Ca2]o with apamin present
(resting membrane potential: 48.61.8 mV, n8),
1 mol/L forskolin significantly reduced EDHF hyperpolar-
ization by 80% to 100% (Figure 1C) and hyperpolarization to
300 mol/L 1-EBIO from 8.51.9 mV to 2.90.9 mV
(n5).
Alteration in [Ca2]o also modified arterial tone (Figure I in
the online data supplement). Increasing [Ca2]o from
1.0 mmol/L relaxed precontracted arteries via endothelial cell
KCa3.1 channels, with complete relaxation obtained in the
presence of 2.5 mmol/L [Ca2]o.
Limiting Smooth Muscle Ca2 Increase Modifies
KCa2.3 and KCa3.1 Channel Input to EDHF
Dilation in Rat Mesenteric Arteries
In the presence of the voltage-gated Ca2 channel (VGCC)
inhibitor nifedipine (10 mol/L) and during depolarization to
phenylephrine (PE) (1 mol/L: 7.21.8 mV, n12), apamin
(50 nmol/L) alone effectively abolished EDHF hyperpolar-
ization (23.41.3 mV hyperpolarization to 3 mol/L ACh
reduced to 1.91.3 mV, n12) (Figure 2A through 2C),
whereas TRAM-34 (1 mol/L) had little effect (hyperpo-
larization to 3 mol/L ACh 19.61.4 mV, n12) (Figure
2B). Hyperpolarization to the direct KCa3.1 channel acti-
vator 1-EBIO (100 or 300 mol/L) was not altered by
nifedipine (control: 3.91.0 and 8.80.8 mV, n4; versus
Figure 1. Summarized data showing the average
change in membrane potential (Em) to cumulative
increases in [ACh] applied to evoke EDHF hyper-
polarization in mesenteric arteries. A, Reducing
[Ca2]o from 2.5 to 1.0 mmol/L depressed the
steady-state hyperpolarization to ACh (n7 and
12, respectively). In 1.0 mmol/L Ca2 and with 50
nmol/L apamin present, 50% hyperpolarization
remained (n4), whereas in 2.5 mmol/L [Ca2]o,
apamin fully blocked hyperpolarization (n13). B,
Histogram summarizing the increase in smooth
muscle membrane potential following endothelial
cell stimulation with 1-EBIO in the presence of 50
nmol/L apamin. In 1.0 mmol/L [Ca2]o, hyperpolarization to both 100 and 300 mol/L 1-EBIO was enhanced (n4 and 5, respectively).
*P0.05 relative to control (2.5 mmol/L [Ca2]o). C, In 1.0 mmol/L [Ca2]o Krebs with 50 nmol/L apamin present, EDHF hyperpolarization
evoked with ACh was significantly inhibited in the additional presence of 1 mol/L forskolin (n8, P0.05).
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nifedipine: 3.50.7 and 6.22.2 mV, n5, respectively).
In the presence of another VGCC inhibitor, diltiazem
(10 mol/L), and PE depolarization (7.00.9 mV, n6),
apamin again effectively abolished EDHF hyperpolariza-
tion (33.01.5 mV hyperpolarization to 3 mol/L ACh
reduced to 5.62.2 mV, n6) (Figure 2C), whereas
subsequent addition of the ATP-sensitive K (KATP) chan-
nel opener levcromakalim (3 mol/L) evoked a robust
hyperpolarization of 29.43.9 mV (n6). Nifedipine re-
duced the smooth muscle cell [Ca2]i and tension increase
to PE (Figure 2D through 2F).
Imaging both global and subcellular increases in endothe-
lial cell [Ca2] to ACh failed to reveal any significant
difference between ACh applied under resting conditions
(baseline) compared with during smooth muscle stimulation
with PE (Figure 3A and 3B). In Figure 3A, the measurement
regions could be limited to the holes through the IEL, where
a Ca increase was clearly observed within endothelial cell
projections.
KCa3.1 Channel or Na/K-ATPase Block
Abolishes EDHF Dilation When a Gap Junction
Uncoupler Is Present
In unstimulated arteries, 30 to 60 minutes of exposure to the
gap junction uncoupler carbenoxolone (100 mol/L) did not
alter either the smooth muscle (501.7 and 50.60.9
mV, n11 and 6, respectively) or the endothelial cell resting
potential (52.41.3 and 51.91.3 mV, n11 and 6).
With ACh, carbenoxolone reduced smooth muscle (EDHF)
hyperpolarization from a maximum of 20.91.2 mV (to
69.71.7 mV, n9) to 9.93 mV (to 60.52.7 mV,
n6) (Figure 4A and 4B) but did not reduce (direct)
endothelial cell hyperpolarization to 1 mol/L ACh (8.91.4
and 8.11.7 mV, n5) (Figure 4C). However, it reversibly
blocked the indirect hyperpolarization recorded from endo-
thelial cells, where hyperpolarization was induced by stimu-
lating KATP channels in the smooth muscle (5 mol/L levcro-
makalim: control 19.82.1 mV, n5; plus carbenoxolone,
0.40.4 mV, n3; after washout, 19.72.0 mV, n3)
(Figure 4C).
Carbenoxolone (100 mol/L) did not alter contraction to
either submaximal or maximal concentrations of PE or the
subsequent EDHF relaxation to ACh during submaximal
contraction. However, in arteries maximally contracted with
PE, the EDHF-mediated relaxation, which under these stim-
ulation conditions relies solely on MEGJs,16 was abolished
even though levcromakalim (1 mol/L) was able to stimulate
maximal relaxation (97.11.0%, n6, Table).
In arteries submaximally stimulated with PE, depolariza-
tion and contraction did not differ from control (control:
Figure 2. ACh-mediated stimulation of
KCa3.1 channels is prevented by blocking
VGCC in rat mesenteric arteries. A, Original
traces demonstrating concentration-
dependent EDHF-induced smooth muscle
hyperpolarization evoked by ACh in the
presence of nifedipine (10 mol/L) and prior
depolarization to PE. Hyperpolarization
overshot the resting membrane potential
(dashed line) and was abolished by apamin
(50 nmol/L). B, Summarized data showing the
average change in membrane potential (Em)
to cumulative increases in [ACh] in arteries
stimulated with PE in the presence of nifedi-
pine (10 mol/L, n4 to 10) or in the addi-
tional presence of either apamin (50 nmol/L,
n4 to 12) or TRAM-34 (1 mol/L, n7 to
14) or both inhibitors together (n5 to 8). C,
Summarized data showing the average
change in membrane potential (Em) to
cumulative increases in [ACh] in arteries stim-
ulated with PE in the presence of diltiazem
(10 mol/L, n4 to 6) or in the additional
presence of apamin (50 nmol/L, n5 to 7). D,
Smooth muscle Ca2 signals in the absence
(upper traces) and presence of nifedipine
(10 mol/L, lower traces) color-coded to the
field of interest shown in the image in E.
Applying 0.6 or 1 mol/L PE stimulated a
marked increase in the global average level
of [Ca2] (black line), representing asynchro-
nous Ca2 increases within individual muscle
cells. Both the average increase and the
majority of the oscillations were abolished in
the presence of nifedipine (see supplemental
Video 1 for the movie corresponding to these
data). F, Summarized data showing inhibition
of the increase in [Ca2]i stimulated by
1 mol/L PE (control [Cont] n6, nifedipine
[Nif] n3) (left) and the associated block of
arterial contraction (paired data) (right).
*P0.05 relative to control baseline.
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9.21.0 mV, 6.30.4 mN; with carbenoxolone: 9.21.6
mV, 6.90.6 mN; n8), but the ACh-evoked increase in
membrane potential was reduced by 10 mV (Figure 4B),
increasing to 63.44.5 mV (n7) compared with
70.92.4 mV (n8) without carbenoxolone. However, this
reduction in maximum hyperpolarization was not sufficient to
modify the associated relaxation. In contrast, in the additional
presence of 1 mol/L TRAM-34, relaxation to ACh was
almost abolished (92.52.8% [n5] reduced to 26.16.7%
[n5]; Figure 4B). Ouabain (100 mol/L) had a similar
inhibitory effect to TRAM-34, depressing relaxation to ACh
(from 98.91.0%) to only 23.55.7% in the presence of
carbenoxolone (n3). In contrast, under similar conditions,
apamin had only a slight inhibitory effect (Figure 4B).
Possible Link Between KCa2.3 Channels and
C-Type Natriuretic Peptide?
Use of the selective natriuretic peptide receptor-C antagonist
M372049 (100 nmol/L) and comparison of EDHF responses
(to ACh) with the action of exogenous C-type natriuretic
peptide (CNP) did not suggest any link between KCa2.3
channel activation and the subsequent activation of natriuretic
peptide receptor-C leading to hyperpolarization and relax-
ation (supplemental Figure II).
Dimensional Localization of Na/K-ATPase and
K Channels Within the Rat Mesenteric Artery
Immunofluorescence indicating Na/K-ATPase 2 (and sim-
ilarly for 3) subunits was distributed throughout the cells
within pressurized rat mesenteric arteries (Figure 5). A
particularly intense, punctate fluorescence signal was dis-
cretely aligned with holes through the IEL and above the
plane of focus of the endothelium, at the interface between
the IEL and the smooth muscle (noted to be an endothelial
cell projection21). This corresponds with regions of MEGJ
formation where we have previously demonstrated colocal-
ization of KCa3.1 channels, connexin (Cx)40, and Cx37.5,16 In
contrast, staining for Kir2.1 channels was homogeneous
within endothelial cells, and that for KCa2.3 channels was very
clear at interendothelial cell borders, similar to staining for
Cx37 and Cx40.5,22 There was also strong staining for Kir,
KCa2.3, and KCa3.1 channels in endothelial cell projections,
whereas staining for KCa3.1 channels and Na/K-ATPase
was not evident (or at least markedly less) in other regions of
the endothelial cells. No immunostaining was observed in
arteries where the primary antibody was omitted during
preparation or following prior incubation with blocking
peptide.
Discussion
These data show that the ability of KCa3.1 channels to
contribute to EDHF hyperpolarization depends on extracel-
lular [Ca2]o, possibly linked to the extent of basal stimulation
of the extracellular CaSRs known to colocalize with these
channels in the mesenteric artery endothelium. Recruitment
of KCa3.1 channels to EDHF hyperpolarization (and relax-
ation) did not appear to reflect Ca2 or a Ca2 release signal
passing from the smooth muscle into the endothelial proj-
ections that form MEGJs. However, it may reflect a local
depletion of extracellular [Ca2]o around the endothelial
projections containing KCa3.1 as [Ca2]o enters the smooth
muscle through VGCC, because recruitment was reduced in
the presence of VGCC blockers to limit the ability of PE to
Figure 3. Similar increases in endothelial cell [Ca2]i evoked with
ACh alone and applied during smooth muscle stimulation with
PE. A, Mesenteric arteries were mounted in a pressure myo-
graph and changes in endothelial cell [Ca2]i assessed at the
interface between the endothelium and the IEL. Upper micrographs
show loaded endothelial cells (average of 20 seconds). Note bright
spots (endothelial cell projections) that correspond to holes in the
IEL (lower micrographs). Bar20 m. Lower micrographs show the
time course of fluorescence changes in individual endothelial cells
in response to ACh (1 mol/L) added under baseline conditions
(left) and in the presence of PE (0. 3 to 0.6 mol/L) (right). Regions
were placed over (color) and adjacent to (gray) the endothelial cell
projections and around the whole cell (black). The colors relate to
subcellular regions within the micrographs (see supplemental Video
2 for the movie corresponding to these data from the region indi-
cated by the black box). Representative of 3 experiments. B, Mes-
enteric arteries were mounted in a wire myograph, and changes in
(whole) endothelial cell [Ca2]i were measured before and during
ACh (1 mol/L), either from baseline or in the presence of PE (0.3
to 0.6 mol/L, n3, paired data). Note that endothelial cell proj-
ections were not loaded in these experiments. (See the expanded
Materials and Methods section in the online data supplement for
details.)
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raise muscle [Ca2]i. Finally, KCa3.1 channel input may be
enhanced by the K ions acting on the same, or closely
adjacent, cells via the Na/K-ATPase (and possibly Kir
channels). This suggests that K efflux through KCa channels
discretely localized in endothelial projections may underlie
its action as a “diffusible” EDHF, whereas hyperpolarization
attributable to KCa channels expressed near interendothelial
cell borders (KCa2.3) relies primarily on extant MEGJs for
effective spread into the media.
In the rat mesenteric artery, we have recently shown that
KCa3.1 channels are concentrated in the head region of
endothelial cell projections protruding through the IEL to
form MEGJs.5 In the endothelial cells, strong punctate signal
for KCa3.1 channels colocalized with Cx37 and Cx40 at the
interface with the smooth muscle. Furthermore, at an ultra-
structural level KCa3.1 channels and both Cx37 and Cx40
conjugated gold label was associated with endothelial cell
projections forming MEGJs. In contrast, although KCa2.3
channels were localized in close proximity to Cx37, Cx40,
and Cx43, they appeared to be mainly adjacent to endothelial–
endothelial cell gap junctions.5,16 These observations correlate
with electrophysiological and immunoprecipitation data. In the
former, the contribution from KCa2.3 and KCa3.1 channels to
ACh-mediated hyperpolarization could be separated. Endothelial
KCa3.1 channel activity was only apparent when the arterial
smooth muscle was depolarized and contracted (leading to
EDHF repolarization to close to resting potential).4 In the
latter, KCa2.3 and KCa3.1 channels were associated with
caveolin-rich and -poor fractions of endothelial cell mem-
brane, respectively.9 The present experiments subtly extend
Table. Carbenoxolone Only Blocks EDHF Relaxation to ACh in Mesenteric Arteries
Maximally Contracted With PE
Tension (mN) PE	 (mol/L) Relaxation (%) pD2 n
Low contraction
Control 10.80.6 0.40.1 96.41.2 7.20.1 5
Carb 8.90.7 0.60.1 92.93.2 6.90.1 5
High contraction
Control 19.02.5 10.00.0 95.40.6 7.00.1 6
Carb 18.61.8 10.00.0 10.37.7* 7.20.5 6
The concentration of carbenoxolone (Carb) was 100 mol/L. Average relaxation to 1 mol/L ACh
obtained in arteries undergoing submaximal (low) contraction or maximal (high) contraction to PE.
*P0.05 relative to control; paired data for each level of tension.
Figure 4. Gap junctions facilitate the contri-
bution of KCa2.3 channels to EDHF hyper-
polarization in rat mesenteric artery. A,
Original traces demonstrating ACh-
mediated concentration-dependent
increases in smooth muscle cell mem-
brane potential from the resting mem-
brane potential (dashed lines). Carbenox-
olone (100 mol/L) did not alter the
resting membrane potential but reduced
the hyperpolarization to ACh. B, Left,
Summarized data showing the average
change in membrane potential (Em) to
cumulative increases in [ACh] to evoke
EDHF hyperpolarization in arteries from
resting membrane potential (n6 to 11).
Middle, In the presence of PE, carbenox-
olone (100 mol/L) depressed EDHF hy-
perpolarization (n5 to 9) but not relax-
ation to ACh (n8 to 14). Right, The
EDHF-mediated relaxation was reduced
by the addition of apamin (50 nmol/L,
n9 to 13) and almost abolished by
TRAM-34 (1 mol/L, n5 to 12) or
ouabain (100 mol/L, n3 to 9), each
applied when carbenoxolone was pres-
ent. *P0.05 relative to control. C, Origi-
nal traces demonstrating, Left, endothelial
cell hyperpolarization to ACh (1 mol/L)
and levcromakalim (5 mol/L). Middle,
carbenoxolone (100 mol/L) blocked
hyperpolarization to levcromakalim not
ACh. Right, average increases in endo-
thelial cell membrane potential before,
during application, and after washout of carbenoxlone, demonstrating reversible block of hyperpolarization to levcromakalim.
ACh, n4, 5, 3; levcromakalim, n5, 3, 3, respectively.
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our morphological data and provide novel insight into the
control of endothelial KCa3.1 channel activation and therefore
their contribution to EDHF responses. Reconstruction of
confocal z-stack images from the wall of mesenteric arteries,
obtained in a physiological orientation (as opposed to perfu-
sion fixation and flat mounting for microscopy),5 confirmed
the restriction of KCa3.1 channels within endothelial cell
projections but also revealed a colocalization of KCa2.3.
With regard to the mechanism responsible for recruiting
the KCa3.1 channels within endothelial cell projections, this
was shown to be sensitive to [Ca2]o around the outside of the
projections. Reducing [Ca2]o recruited KCa3.1 channels to
EDHF hyperpolarization. These observations are consistent
with recent evidence in lean Zucker rats, in which both KCa2.3
and KCa3.1 channels contributed to EDHF hyperpolarization
in arteries bathed in Krebs containing 1.6 mmol/L [Ca2].2 A
reasonable explanation in both studies is that lowering [Ca2]o
reduces basal stimulation of an extracellular G protein–linked
CaSR, receptors known to colocalize with KCa3.1 channels in
“noncaveolin” membrane fractions of mesenteric endothelial
cells.9 Thus, lowering [Ca]o from 2.5 to 1 mmol/L reduced
extracellular CaSR saturation and effectively increased avail-
ability of membrane KCa3.1 channels for activation by in-
creases in [Ca2]i within the endothelial projections.
Limiting increases in smooth muscle [Ca2]i was also
linked to the ability of endothelial KCa3.1 channels to provide
significant input to EDHF hyperpolarization. Nifedipine or
diltiazem reduced voltage-dependent Ca2 entry into the
smooth muscle, associated with a loss of KCa3.1 channel input
to the EDHF response (evoked by ACh) and, as a conse-
quence, sole reliance on the activation of apamin-sensitive
KCa2.3 channels. One possible explanation is that during
“normal” increases in smooth muscle [Ca2]i, KCa3.1 channel
input to the EDHF response is enabled because the increase in
smooth muscle [Ca2]i following depolarization indirectly
facilitates Ca2 signaling in the endothelial cell projections
and activates the channels. Direct measurement of endothelial
cell [Ca2]i levels in both resistance arteries and arterioles has
shown that smooth muscle stimulation with PE leads to
[Ca2]i increases in the endothelium.6–8 In isolated mesenteric
Figure 5. Endothelial cell immunohistochemical
expression pattern for Na/K-ATPase, Kir2.1,
KCa3.1, and KCa2.3 channels in rat mesenteric
arteries. A through D, Top, Confocal images of the
wall of pressurized arteries showing a single z-axis
plane through the IEL (green) and simultaneously
acquired corresponding expression of protein
(red). A through D, Bottom, Reconstruction of the
confocal z-axis multiplane stack through the wall
of the artery corresponding to a line drawn
through the images in the upper panels at the
positions indicated by arrows. Note the presence
of protein staining within the holes through the IEL
in both the top and bottom images. Both the Na/
K-ATPase 2 subunit and KCa3.1 channels are
highly expressed within the holes, whereas Kir2.1
and KCa2.3 channels are also highly expressed
within endothelial cells and at endothelial cell bor-
ders, respectively. In these images, the Alexa Fluor
488 secondary antibody was only applied to the
luminal side of the artery, and the confocal laser
and PMT settings were identical for each z-stack.
Bar indicates 20 m in the x-axis in all images.
Representative of at least 3 arteries. E, Quantifica-
tion of protein expression within the holes through
the IEL (n3 to 5). [Holes], number of holes in the
IEL/100 m2.
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arteries from the rat, endothelial cell subpopulations dis-
played an increase in Ca2 during muscle stimulation with
PE, apparently reflecting spread of inositol-1,4,5-
trisphosphate from the muscle to the endothelium.7 However,
the additional movement of Ca2 into endothelial cell proj-
ections (and throughout the cells)8,23 could not be discounted
by these experiments. However, signaling via this route does
not appear to explain our data. We were unable to detect any
difference in [Ca2]i increases to ACh within the endothelial
cell projection (or whole cell) during simultaneous muscle
stimulation with PE. The caveat here is that it remains
possible the resolution and limitations of our system pre-
vented detection of very small and localized changes within
endothelial cell projections or discrete changes in [Ca2]i
within the projections during changes in diameter.
Alternatively, Ca2 entry into the contracting muscle itself
may be sufficient normally to reduce the [Ca2]o in the
restricted extracellular space round the endothelial cell proj-
ection. As such, this would reduce “basal” CaSR stimulation
and facilitate linked KCa3.1 channel availability, enabling
activation of the latter by the increased [Ca2]i in the
projections evoked by ACh. In support of this scenario,
during synchronous neuronal activity the opening of VGCCs
is known to substantially deplete (1 mmol/L) extracellular
[Ca2]o in the limited volume of fluid surrounding the
cells.24–26 Whatever the precise explanation, within endothe-
lial cell projections KCa3.1 channel activity may be sup-
pressed through the action of protein kinase A. In enteric
neurons, protein kinase A appears to maintain the KCa3.1
currents underlying slow, postspike, after-hyperpolarization
in a closed state.10 In our experiments, the ability of forskolin
to inhibit EDHF hyperpolarization attributable to KCa3.1
channel activity suggests a similar mechanism operates in
mesenteric endothelial cells.
One possible confounding influence in our experiments
with VGCC blockers is the potential for nifedipine directly to
block KCa3.1 channels. Dihydropyridines were initially shown
to block the Gardos channel in erythrocytes,27,28 and, more
recently, Jiang et al29 reported block of EDHF hyperpolariza-
tion in guinea pig cochlear artery, in which, in contrast to the
mesenteric artery, hyperpolarization appears to depend on
KCa3.1 channels alone. However, this did not appear to be a
significant consideration in our experiments because: (1)
diltiazem, which unlike the dihydropyridines does not block
KCa3.1 channels,27,29 had a similar effect to nifedipine; and (2)
nifedipine did not alter hyperpolarization to the KCa3.1
channel activator 1-EBIO. The apparent inability of nifed-
ipine to block KCa3.1 channels may relate to the experi-
mental conditions. For example, block of the Gardos
channel with nifedipine decreases with increasing extra-
cellular K, a situation that would be predicted in our
experiments in the presence of PE,27 or it may simply be
that although KCa3.1 channel activation is reduced, the
reduction is not sufficient to suppress the overall EDHF
hyperpolarization in intact arteries.
Another important observation in our study was the ability
of either ouabain or TRAM-34 to block EDHF responses in
the presence of the gap junction uncoupler carbenoxolone.
Although carbenoxolone did reduce EDHF hyperpolarization,
this did not modify the associated arterial relaxation. How-
ever, once ouabain was added along with carbenoxolone,
EDHF relaxation was abolished. Although this concentration
of ouabain blocks smooth muscle hyperpolarization and
relaxation to exogenous K,17 it has only a small inhibitory
effect against the overall EDHF hyperpolarization and relax-
ation in submaximally contracted arteries, because the EDHF
response is sustained by MEGJs, as explained in the intro-
duction.13,16 However, once the MEGJ pathway is compro-
mised, in this case with carbenoxolone, blocking the action of
endogenous K significantly impacts on EDHF relaxation.
The fact that a gap junction uncoupler (carbenoxolone) did
not alter EDHF responses in submaximally contracted arter-
ies, but abolished them in maximally contracted arteries,
although not altering relaxation to levcromakalim, supports
this scheme. Interestingly, with carbenoxolone present in
submaximally contracted arteries, TRAM-34 (but not
apamin) caused similar block to ouabain. This suggests that
endogenous K originating from the KCa3.1 channels in close
proximity to focused clusters of Na/K-ATPase underlies
the ability of K to act as EDHF. In the absence of
carbenoxolone, block of both KCa3.1 and KCa2.3 channels,
with TRAM-34 and apamin together, is necessary to block
EDHF effects.4 The concentration of carbenoxolone we used
has been shown not to alter the [Ca2]i increase evoked in the
endothelium with ACh,16 and it blocks the spread of calcein
from the endothelium into the smooth muscle.8 Furthermore,
we now show that carbenoxolone does not modify the resting
potential in either the endothelial or smooth muscle cells nor
the endothelial cell hyperpolarization evoked with ACh.
However, notably, it did block hyperpolarization to levcro-
makalim from spreading through MEGJs to the endothelium.
In this vessel, KATP channels are found only on the smooth
muscle cells and not the endothelium.30 Therefore, although it
remains possible carbenoxolone has effects in addition to
uncoupling gap junctions, this agent clearly and effectively
blocks the spread of EDHF hyperpolarization through MEGJs
and without disrupting the key events responsible for initiat-
ing an EDHF response via Ca2 handling and KCa channel
activation within the endothelium.
Finally, in rat mesenteric arteries, KCa2.3 channel activa-
tion has recently been suggested to be somehow linked to the
release of CNP, with CNP then acting as an EDHF to
hyperpolarize and relax the adjacent smooth muscle.20 Fur-
thermore, in this study, the natriuretic peptide receptor-C–
selective antagonist M372049 was found to act synergisti-
cally with ouabain to block EDHF responses, leading to the
suggestion that CNP acts alongside a KCa3.1-dependent sig-
nal, the 2 “arms” underpinning the EDHF response in
mesenteric arteries. Although a link between KCa3.1 channels
and Na/K-ATPase activation is consistent with our data, we
were unable to provide any evidence to suggest that CNP
plays a significant role in the EDHF response. Although
M372049 clearly blocked arterial relaxation to exogenous
CNP, it did not increase the inhibitory action of ouabain
against EDHF hyperpolarization and relaxation, and it failed
to inhibit the apamin-sensitive (KCa2.3 channel) component of
EDHF hyperpolarization. The fact that exogenous CNP only
evoked a modest relaxation without any hyperpolarization,
Dora et al Differential Endothelial Cell K Channel Activation 1253
and that M372049 did not modify EDHF responses to ACh,
also argues strongly against a significant role for CNP in the
EDHF response.
Overall, our data indicate a clear correlation between the
discrete localization of KCa3.1 channels within the endothelial
cell projections that form MEGJs and their respective activa-
tion during smooth muscle stimulation. A suggested outline
mechanism is presented in Figure 6. The complex dynamics
of [Ca2]o change within the very restricted intercellular space
between muscle and endothelial cell projections may provide
the key to explaining why KCa3.1 channels are able to
contribute to EDHF hyperpolarization and relaxation during
muscle contraction, dropping out as membrane potential and
tension (reflecting smooth muscle [Ca2]i) return to resting
levels, while KCa2.3 channels still continue to increase mem-
brane potential to close to EK. In addition, spatial clustering of
KCa3.1 channels and Na/K-ATPase in a concentrated mi-
crodomain within the endothelial cell projections may serve
to focus K efflux for optimal stimulation of the pump, thus
amplifying and/or initiating EDHF hyperpolarization in the
smooth muscle cells.
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